SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is at the center of intense debate following a cryptic social media post from its CEO regarding balance sheet strengthening and global expansion, fueling speculation about potential non-dilutive capital or strategic partnerships. While some investors fear further dilution, the community is largely focused on upcoming international expansion milestones and potential government-backed funding, viewing the current volatility as a battleground between persistent short-selling pressure and long-term bullish conviction in the company's clinical pipeline.

Spdr Dow Jones Industrial Average ETF Trust - Units of undivided interest in DIAMONDS Trust Series 1

The SPDR Dow Jones Industrial Average ETF (DIA) is currently at the center of market volatility as investors weigh conflicting reports over the potential resolution of the U.S. military campaign in Iran. While some traders are reacting to speculative optimism regarding a diplomatic wind-down, the community remains deeply divided, with many debating the impact of energy supply disruptions and the sustainability of market rallies amidst persistent geopolitical uncertainty.

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

SPY is rallying in after-hours trading following reports that the U.S. is prepared to conclude military operations against Iran even if the Strait of Hormuz remains closed. While the news sparked an immediate surge in equity futures and a cooling in oil prices, the community remains deeply divided, with many traders debating whether this is a genuine de-escalation or a tactical 'pump and dump' setup ahead of potential further conflict.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

MullenArmy (MULN) is trending as retail investors engage in a polarized debate over its transition into the crypto space, with some community members promoting it as a community-driven project while many others dismiss it as a continuation of previous stock-based manipulation schemes. Sentiment remains heavily divided, with vocal critics highlighting past dilution and reverse splits, while optimistic supporters focus on its potential as a grassroots movement.

Maul Coin

Maul Coin is trending as the community rallies around the founder's transparent, high-school-teacher-led project while actively managing volatility from whale activity. Investors are heavily focused on organic growth and the push for official listing updates and chart integration to sustain momentum.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently experiencing significant downward pressure as it navigates a broader tech sector sell-off and investor apprehension regarding geopolitical instability in the Middle East. While retail sentiment remains deeply polarized between those betting on long-term AI-driven fundamental growth and those expecting a deeper valuation reset, the community is actively debating whether the current pullback represents a strategic buying opportunity or a signal of structural weakness.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GE Aerospace is currently trending due to active investor focus on potential margin risks surrounding upcoming shareholder votes on ESG-related proposals, alongside broader market debates regarding the sustainability of its high-margin service business amidst geopolitical and defense-sector volatility. The community remains closely divided, balancing bullish optimism regarding the company's recurring revenue moat and defense backlog against concerns over governance uncertainties and recent technical price weakness.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics Holdings is facing intense scrutiny as investors weigh the promise of its Eversense 365 implantable CGM technology against ongoing frustrations with management's execution, recurring cash burn, and the potential for further dilution. While community sentiment remains divided between hopeful longs banking on eventual institutional adoption or a buyout and vocal critics pushing for leadership changes, the stock continues to be heavily traded as a volatility play amid a lack of consistent commercial growth.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is experiencing heightened volatility as market participants debate whether recent price swings are driven by legitimate AI-driven fundamental growth or external noise related to sector-wide tech selloffs and shifting ad-tech competition. The community remains deeply divided, with some investors accumulating positions on dips due to strong institutional support and buyback programs, while others express caution regarding potential short-seller narratives and broader macro-economic pressures.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is experiencing significant downward pressure as investors rotate out of AI-linked semiconductor stocks following reports of Googles new memory-compression algorithm, TurboQuant, which fueled concerns about future demand for memory chips. The community remains deeply divided, with some investors panic-selling into a deepening technical breakdown while others aggressively argue the stock is a long-term value play, pointing to historical earnings strength and arguing that current volatility is driven by macro-headwinds and market manipulation rather than fundamental flaws.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sana Biotechnology (NASDAQ:SANA) Trading Down 7.2% - Here's What Happened

Sana Biotechnology (NASDAQ:SANA) Shares Down 7.2% - Here's Why...

Sana Biotechnology, Inc. (NASDAQ:SANA) Given Average Recommendation of "Moderate Buy" by Brokerages

Sana Biotechnology, Inc. (NASDAQ:SANA - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the eight analysts that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation and s...

Sana Biotechnology (NASDAQ:SANA) Trading Up 7.8% - Here's What Happened

Sana Biotechnology (NASDAQ:SANA) Trading 7.8% Higher - Still a Buy...

Sana Biotechnology (SANA) Expected to Announce Quarterly Earnings on Monday

Sana Biotechnology (NASDAQ:SANA) will be releasing its Q4 2025 earnings before the market opens on Monday, March 16. (View Earnings Report at...

Q1 EPS Estimate for Sana Biotechnology Lowered by Analyst

Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) - Equities research analysts at HC Wainwright dropped their Q1 2026 EPS estimates for Sana Biotechnology in a report issued on Wednesday, March...

Sana Biotechnology (NASDAQ:SANA) Stock Price Down 9.7% After Analyst Downgrade

Sana Biotechnology (NASDAQ:SANA) Trading Down 9.7% Following Analyst Downgrade...

What is HC Wainwright's Forecast for SANA FY2030 Earnings?

Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) - Analysts at HC Wainwright issued their FY2030 earnings estimates for Sana Biotechnology in a report issued on Wednesday, March 4th. HC...

Sana Biotechnology (NASDAQ:SANA) Cut to Hold at Zacks Research

Zacks Research lowered shares of Sana Biotechnology from a "strong-buy" rating to a "hold" rating in a report on Tuesday...

Sana Biotechnology (NASDAQ:SANA) Price Target Lowered to $7.00 at HC Wainwright

HC Wainwright reduced their target price on Sana Biotechnology from $9.00 to $7.00 and set a "buy" rating for the company in a research note on Wednesday...

Sana Biotechnology, Inc. (NASDAQ:SANA) Given Consensus Recommendation of "Moderate Buy" by Analysts

Sana Biotechnology, Inc. (NASDAQ:SANA - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the nine analysts that are covering the firm, Marketbeat reports. One equities...

Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.

Sana Biotechnology Inc

Patrick OShaughnessy - @patrick_oshag on X

Citrini - @Citrini7 on X

Bucco Capital - @buccocapital on X

Joe Weisenthal - @TheStalwart on X

The must-watch individual or show that brings entertainment to finance. This award celebrates the content you look forward to daily - bringing a sharp market edge to engaging discussions. 

Current Price	$2.68
Prev Close	$2.77
Open	$2.83
Dividend Yield	0.00%
50-Day Moving Average	$3.85
Beta	2.02
Avg. Volume	1.97M
PE Ratio	-2.74

52-Week High	$6.55
52-Week Low	$1.26
Market Capitalization	$739.22M
EPS (Annual)	-$0.9642
Price to Book	4.44
Revenue Per Employee	$0.00

SANA
Sana Biotechnology Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SANA News

SANASana Biotechnology Inc